hemacord.info valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
# www.robotstxt.org # goo.gl/JzIqS User-agent: * Disallow: /harming/humans Disallow: /ignoring/human/orders Disallow: /harm/to/self Allow:
Meta Tags
Title HEMACORD (HPC, Cord
Description Get the information that’s right for HEMACORD® (HPC, Cord Blood) For Physicians For Patients For Transplant Centers Contact We are pleased to announce the availability of HEMACORD® (HPC, Cord
Keywords N/A
Server Information
WebSite hemacord faviconhemacord.info
Host IP 20.120.80.220
Location United States
Related Websites
Site Rank
More to Explore
hemacord.info Valuation
US$396,507
Last updated: 2023-05-13 07:59:49

hemacord.info has Semrush global rank of 26,693,877. hemacord.info has an estimated worth of US$ 396,507, based on its estimated Ads revenue. hemacord.info receives approximately 45,751 unique visitors each day. Its web server is located in United States, with IP address 20.120.80.220. According to SiteAdvisor, hemacord.info is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$396,507
Daily Ads Revenue US$367
Monthly Ads Revenue US$10,981
Yearly Ads Revenue US$131,763
Daily Unique Visitors 3,051
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
hemacord.info. A 299 IP: 20.120.80.220
hemacord.info. NS 86400 NS Record: coby.ns.cloudflare.com.
hemacord.info. NS 86400 NS Record: ashley.ns.cloudflare.com.
HtmlToTextCheckTime:2023-05-13 07:59:49
HEMACORD® (HPC, Cord Blood) For Physicians For Patients For Transplant Centers Contact We are pleased to announce the availability of HEMACORD® (HPC, Cord Blood), the first FDA approved allogeneic cord-blood derived hematopoietic stem cell therapy product There are thousands of HEMACORD® (HPC, Cord Blood) units available in inventory to provide the best possible matches. Get the information that’s right for you For Physicians For Patients For Transplant Centers Indications and Usage For use in unrelated donor hematopoietic progenitor cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment. The risk benefit assessment for an individual patient depends on the patient characteristics, including disease, stage, risk factors, and specific manifestations of the disease, on
HTTP Headers
HTTP/1.1 200 OK
Server: nginx
Date: Tue, 21 Dec 2021 00:38:33 GMT
Content-Type: text/html; charset=utf-8
Content-Length: 13414
Last-Modified: Fri, 10 Dec 2021 18:02:30 GMT
Connection: keep-alive
Vary: Accept-Encoding
ETag: "61b39636-3466"
Expires: Wed, 22 Dec 2021 00:38:33 GMT
Cache-Control: max-age=86400
Cache-Control: public
X-UA-Compatible: IE=Edge,chrome=1
Accept-Ranges: bytes
hemacord.info Whois Information
Domain Name: hemacord.info
Registry Domain ID: b585eb1651c54448880f4135e0e49699-DONUTS
Registrar WHOIS Server: http://whois.cloudflare.com
Registrar URL: http://cloudflare.com
Updated Date: 2021-12-09T21:04:51Z
Creation Date: 2012-12-14T20:34:18Z
Registry Expiry Date: 2022-12-14T20:34:18Z
Registrar: Cloudflare, Inc
Registrar IANA ID: 1910
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Registrant Organization: DATA REDACTED
Registrant State/Province: New York
Registrant Country: US
Name Server: ashley.ns.cloudflare.com
Name Server: coby.ns.cloudflare.com
DNSSEC: unsigned
>>> Last update of WHOIS database: 2021-12-24T19:01:56Z <<<